Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.72    0.48 (1.40%)
Bid:
34.80
Ask:
35.52
Spread: 0.72 (2.069%)
Market Cap: £555.18m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

CEO Appointment

18 May 2026 07:00

RNS Number : 6821E
Hays PLC
18 May 2026
 

18 May 2026

Hays plc ("Hays")

Chief Executive Officer Appointment

 

Hays today announces the appointment of Mark Dearnley as Chief Executive Officer ("CEO") with immediate effect, having served as interim CEO since 27 February 2026.

Mark is a highly experienced senior executive with a strong track record of leading digital and business transformation across multiple industries. Prior to being appointed interim CEO, Mark was Hays Chief Digital and Technology Officer. He joined Hays from Inchcape plc, where he held the role of Group Chief Digital Officer. Other previous roles include Partner at Bain & Company, Chief Digital & Information Officer at HM Revenue & Customs, and Chief Information Officer, UK at Vodafone Group plc. He is currently a Trustee at The King's Trust.

 

Michael Findlay, Chair of Hays, said:

"The Board is delighted to appoint Mark as CEO. Following a comprehensive external and internal search, the Board unanimously felt that Mark has the outstanding leadership skills and experience to lead the business forward.

Mark brings significant experience in driving transformation across large, global organisations. His expertise in this landscape will be hugely valuable to Hays as the industry navigates fundamental changes and macroeconomic uncertainty. As Group Chief Digital and Technology Officer, and more recently as interim CEO, he has developed a strong understanding of our business and the needs of our clients. We look forward to working with him as he leads Hays in its next phase."

 

Mark Dearnley said:

"I am very excited to be taking on this role. I feel really energised by what we can achieve together at Hays, and confident in the direction we will be taking as a business.

Serving as interim CEO over the past few months has only reinforced what I already knew, this is a brilliant business with great people, a huge amount of purpose and massive potential."

 

No further information is required to be disclosed pursuant to Listing Rule 6.4.8R.

ENDS

 

Enquiries

Hays plc

Rachel FordKean Marden

FGS GlobalGuy Lamming / Anjali Unnikrishnan / Richard Crowley

 

General Counsel & Company Secretary

Head of Investor Relations and M&A

 

+44 (0) 333 010 2682

+44 (0) 333 010 7092hays@fgsglobal.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFFFMWEMSEEI
Date   Source Headline
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 202511:00 amRNSShare buyback programme
10th Oct 20257:00 amRNSFirst Quarter Trading Statement
6th Oct 202512:00 pmRNSPublication of Annual Report and Notice of AGM
3rd Oct 202511:09 amRNSDirector/PDMR Shareholding
1st Oct 202510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.